| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/22/2002 | CA2097801C Method of producing collagen particles, and the use of such particles as substrates for active substances |
| 01/22/2002 | CA2057711C Antibiotic agent |
| 01/22/2002 | CA2050304C Pharmaceutical composition useful in preventing or treating tumors induced by papillomaruses |
| 01/22/2002 | CA2038848C Hydantoin derivatives |
| 01/22/2002 | CA2038398C Dna encoding a growth factor specific for epithelial cells |
| 01/22/2002 | CA1341334C Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
| 01/22/2002 | CA1341333C Amylin peptides and uses thereof |
| 01/21/2002 | CA2313449A1 Engineering salt tolerance in crop plants |
| 01/17/2002 | WO2002005146A2 Method for disigning protein libraries with altered immunogenicity |
| 01/17/2002 | WO2002004949A2 Reagents and methods for identification of binding agents |
| 01/17/2002 | WO2002004685A1 Method for determining three-dimensional protein structure from primary protein sequence |
| 01/17/2002 | WO2002004665A2 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors |
| 01/17/2002 | WO2002004651A2 Jointless gene of tomato |
| 01/17/2002 | WO2002004647A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
| 01/17/2002 | WO2002004646A1 Expression system |
| 01/17/2002 | WO2002004643A1 Tumor necrosis factor-gamma |
| 01/17/2002 | WO2002004642A1 Novel polypeptide and dna thereof |
| 01/17/2002 | WO2002004641A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004640A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004639A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004638A1 Compounds targeted to cellular locations |
| 01/17/2002 | WO2002004637A1 Myocardium-specific promoter |
| 01/17/2002 | WO2002004636A1 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS |
| 01/17/2002 | WO2002004635A1 A novel polypeptide, a human mbll zinc finger protein 39 and the polynucleotide encoding the polypeptide |
| 01/17/2002 | WO2002004634A1 A novel polypeptide, a human apoptosis relative protein 9.46 and the polynucleotide encoding the polypeptide |
| 01/17/2002 | WO2002004633A1 A novel polypeptide, a human fascicular and elongation protein 12.87 and the polynucleotide encoding the polypeptide |
| 01/17/2002 | WO2002004632A1 A novel polypeptide, a human latexin protein 53 and the polynucleotide encoding the polypeptide |
| 01/17/2002 | WO2002004631A1 A novel polypeptide, a human l1 factor orf2 inverse transcription relative protein 11 and the polynucleotide encoding the polypeptide |
| 01/17/2002 | WO2002004626A1 Fungal cell wall synthesis gene |
| 01/17/2002 | WO2002004625A1 α-SYNUCLEIN BINDING PROTEIN |
| 01/17/2002 | WO2002004624A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004615A1 Method for the production of hydroxylated collagen-like compounds |
| 01/17/2002 | WO2002004614A2 Genes encoding sinapoylglucose: malate sinapoyltransferase and methods of use |
| 01/17/2002 | WO2002004609A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 01/17/2002 | WO2002004602A1 Transformed yeast presenting protein a on the cell surface layer |
| 01/17/2002 | WO2002004601A2 Mammalian mdm2 binding proteins and uses thereof |
| 01/17/2002 | WO2002004600A2 Novel compounds |
| 01/17/2002 | WO2002004599A2 Placental protein having multiple egf-like domains |
| 01/17/2002 | WO2002004596A2 Diagnosing and treating cancer cells using mutant viruses |
| 01/17/2002 | WO2002004595A2 Production of chimeric human papillomavirus |
| 01/17/2002 | WO2002004526A2 Production of a cellulose-like polysaccharide by peudomonas fluorescens |
| 01/17/2002 | WO2002004523A2 Artificial antibody polypeptides |
| 01/17/2002 | WO2002004522A2 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 01/17/2002 | WO2002004521A2 Proteins with integrin-like activity |
| 01/17/2002 | WO2002004520A2 Transporters and ion channels |
| 01/17/2002 | WO2002004519A2 Murine cytokine receptor |
| 01/17/2002 | WO2002004518A2 Human neuropeptide y-like g protein-coupled receptor |
| 01/17/2002 | WO2002004517A1 A putative g-protein coupled receptor for gamma butyric acid (gab9) |
| 01/17/2002 | WO2002004515A1 Insulin derivatives and synthesis thereof |
| 01/17/2002 | WO2002004514A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/17/2002 | WO2002004513A2 Down syndrome critical region 1-like 1 proteins |
| 01/17/2002 | WO2002004512A2 Purification of human troponin i |
| 01/17/2002 | WO2002004511A2 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 01/17/2002 | WO2002004510A2 Gtp-binding proteins |
| 01/17/2002 | WO2002004509A2 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 01/17/2002 | WO2002004508A1 Tumour-associated antigen (b345), characterised by an amino acid sequence as in seq. id. no. 4 |
| 01/17/2002 | WO2002004506A1 A new polypeptide- human rna binding protein 19 and the polynucleotide encoding it |
| 01/17/2002 | WO2002004505A1 A novel polypeptide - human semaphorin protein 9 and a polynucleotide encoding the same |
| 01/17/2002 | WO2002004504A1 A novel polypeptide - human g-protein subunit 9.46 and a polynucleotide encoding the same |
| 01/17/2002 | WO2002004503A1 A new polypeptide- human l1 factor orf2 reverse transcription-related protein 15 and the polynucleotide encoding it |
| 01/17/2002 | WO2002004502A1 A NEW POLYPEPTIDE- MURINE ZINC FINGER PROTEIN (Zfp-1)16 AND THE POLYNUCLEOTIDE ENCODING IT |
| 01/17/2002 | WO2002004500A1 A new polypeptide- human zinc finger protein fpm315-17 and the polynucleotide encoding it |
| 01/17/2002 | WO2002004499A1 Chemokine receptor modulators, production and use |
| 01/17/2002 | WO2002004497A2 Multiple antigenic peptides immunogenic against streptococcus pneumoniae |
| 01/17/2002 | WO2002004496A2 Fimh adhesin proteins and methods of use |
| 01/17/2002 | WO2002004495A2 Streptococcus pyogenes antigen |
| 01/17/2002 | WO2002004494A2 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof |
| 01/17/2002 | WO2002004493A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/17/2002 | WO2002004492A2 Herpes zinc finger motifs |
| 01/17/2002 | WO2002004491A2 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip) |
| 01/17/2002 | WO2002004490A2 Lipid metabolism molecules |
| 01/17/2002 | WO2002004489A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 01/17/2002 | WO2002004488A2 Nucleic acid binding polypeptides |
| 01/17/2002 | WO2002004487A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 01/17/2002 | WO2002004486A2 Bi-functional fusion proteins from hirudin and tap |
| 01/17/2002 | WO2002004485A1 Haemagglutinin antigen |
| 01/17/2002 | WO2002004484A2 Hcv mosaic antigen composition |
| 01/17/2002 | WO2002004482A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 01/17/2002 | WO2002004481A2 Process to increase protein stability |
| 01/17/2002 | WO2002004480A2 Connective tissue growth factor-2 |
| 01/17/2002 | WO2002004028A1 Methods of modulating wound healing and angiogenesis |
| 01/17/2002 | WO2002004018A2 Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
| 01/17/2002 | WO2002004015A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/17/2002 | WO2002004014A1 New class of bioactive glycoprotein |
| 01/17/2002 | WO2002004007A2 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof |
| 01/17/2002 | WO2002003922A2 Synthetic peptide for neurological disorders |
| 01/17/2002 | WO2002003917A2 Alphavirus vectors and virosomes with modified hiv genes for use as vaccines |
| 01/17/2002 | WO2002003911A2 Prevention and treatment of alzheimer's disease |
| 01/17/2002 | WO2002003793A2 Transgenic mice containing targeted gene disruptions |
| 01/17/2002 | WO2002003792A2 Transgenic mice containing targeted protease inhibitor gene disruptions |
| 01/17/2002 | WO2002003789A2 Transgenic mice containing targeted gpcr gene disruptions |
| 01/17/2002 | WO2001079296B1 Humar emr2, a g-protein coupled receptor from the egf-tm7 family |
| 01/17/2002 | WO2001072962A3 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/17/2002 | WO2001070981A3 Nucleic acids and polypeptides of invertebrate g-protein coupled receptors and methods of use |
| 01/17/2002 | WO2001062786A3 Tlp peptides and dna sequences coding the same |
| 01/17/2002 | WO2001061006A3 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same |
| 01/17/2002 | WO2001058952A3 Constitutively open voltage-gated k+ channels and methods for discovering modulators thereof |
| 01/17/2002 | WO2001055342A3 Synthetic genes for enhanced expression |
| 01/17/2002 | WO2001055299A3 Isolated polynucleotide encoding a novel phosphate transporter in plants and a method of modulating phosphate uptake in plants |
| 01/17/2002 | WO2001054651A3 Modulation of gene expression in formation of fatty atherosclerotic lesions |